Marker Therapeutics MRKR
NASDAQ MRKR
$1.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Cash from Discontinued Operations (2022 - 2023)

Updated

Marker Therapeutics' Cash from Discontinued Operations was -$62,938 in Q4 2023, compared with -$2.2 million a year earlier.

Analysis

Marker Therapeutics (MRKR) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends

For FY2023, Cash from Discontinued Operations at Marker Therapeutics came in at -$6.1 million.

  • In earlier years, Cash from Discontinued Operations was -$5.46 million in FY2022.
  • Per Business Quant data, MRKR's Cash from Discontinued Operations in the three quarters before Q4 2023 was -$260,281 (Q3 2023), -$2.99 million (Q2 2023) and -$2.79 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Marker Therapeutics 17.53 Mn -42.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -62,938.00
Sep 30, 2023 -260,281.00
Jun 30, 2023 -2.99 Mn
Mar 31, 2023 -2.79 Mn
Dec 31, 2022 -2.20 Mn
Sep 30, 2022 -2.40 Mn
API Access

Marker Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=MRKR&period=max&api_key=YOUR_API_KEY